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Cough associated with exertion is often used as a surrogate marker of asthma. However,
to date there are no studies that have objectively measured cough in association with
exercise in children. Our primary aim was to examine whether children with a pre-existing
cough have an increase in cough frequency during and post-exercise. We hypothesized
that children with any coughing illness will have an increase in cough frequency post-
exercise regardless of the presence of exercise-induced broncho-constriction (EIB) or atopy.
In addition, we hypothesized that Fractional exhaled nitric oxide (FeNO) levels decreases
post-exercise regardless of the presence of EIB or atopy. Children with chronic cough and
a control group without cough undertook an exercise challenge, FeNO measurements and
a skin prick test, and wore a 24-h voice recorder to objectively measure cough frequency.
The association between recorded cough frequency, exercise, atopy, and presence of EIB
was tested. We also determined if the change in FeNO post exercise related to atopy or
EIB. Of the 50 children recruited (35 with cough, 15 control), 7 had EIB. Children with cough
had a significant increase in cough counts (median 7.0, inter-quartile ranges, 0.5, 24.5) com-
pared to controls (2.0, IQR 0, 5.0, p=0.028) post-exercise. Presence of atopy or EIB did
not influence cough frequency. FeNO level was significantly lower post-exercise in both
groups but the change was not influenced by atopy or EIB. Cough post-exertion is likely
a generic response in children with a current cough. FeNO level decreases post-exercise
irrespective of the presence of atopy or EIB. A larger study is necessary confirm or refute
our findings.
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INTRODUCTION
Cough is one of the most common symptoms presenting to doc-
tors and when present in children, is associated with impaired
quality of life and burden to parents (1). Cough associated with
exercise is often considered a symptom of asthma. (2, 3) How-
ever, some clinicians have observed that exercise can exacerbate
cough in any child with a pre-existing cough, irrespective of diag-
nosis. Yet, in adult studies on cough sensitivity to fog (which is
dependent on minute volume), desensitization of the cough reflex
occurs post-exercise (4). Increased cough is usually associated with
increased cough reflex sensitivity. (5) Thus, there is controversy
on the relationship between cough and exercise and there are
currently no published data that have measured cough frequency
objectively pre- and post-exercise in children. Indeed there is lit-
tle published research on cough and exercise in either adults or
children (6).
Fractional exhaled nitric oxide (FeNO), is an eosinophilic
inflammatory marker measured by a non-invasive test. It is ele-
vated in steroid-naïve children with atopy and asthma. Some have
advocated its use to diagnose and/or monitor asthma (7). There
are no reported studies examining FeNO in children with exercise-
associated cough in the absence of exercise-induced broncho-
constriction (EIB). Two studies on children with asthma provided
conflicting results regarding the relationship between FeNO and
EIB. Terada et al. (8) stated that FeNO decreased during EIB,
whereas Scollo et al. (9) concluded that FeNO did not change
in children with asthma after an exercise challenge.
In the absence of any prospective study relating cough fre-
quency to exercise and FeNO, we recruited 50 children with and
without EIB. Our primary aim was to examine whether children
with a pre-existing cough have an increase in cough frequency
during and post-exercise and whether the presence of EIB and/or
atopy influenced cough frequency. We also determined if any
FeNO change post-exercise is related to the presence of atopy
or EIB.
We hypothesized that children with any coughing illness have
an increase in cough frequency post-exercise regardless of the pres-
ence of EIB or atopy. In addition, we hypothesized that FeNO
levels decreases post-exercise regardless of the presence of EIB or
atopy.
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MATERIALS AND METHODS
PARTICIPANTS
The inclusion criteria were children aged over 6 years. Coughers
had a current chronic (duration >4 weeks) cough at the time of
testing. Children with cough were recruited from the outpatient
clinics when the clinicians looking after these children were query-
ing if the cough was related to EIB. Controls were children without
a current cough and were otherwise well. Controls were recruited
from family and friends. We excluded children who were unable
to either perform spirometry or run on a treadmill.
The study was approved by the Ethics Committee of the
Children’s Health Services, Brisbane. Informed and written con-
sent was obtained from all parents of participants and assent
from appropriately aged children. The clinical trial was regis-
tered with the Australia New Zealand Clinical Trials Registry
(ACTRN12607000511437).
PROTOCOL
Children and their parents were approached when they attended a
routine clinic visit at the tertiary hospital. After informed consent
was obtained (Figure 1), we recorded the child’s demographics. A
series of tests were performed over 2 days. On day 1 all children
undertook: pre-baseline measurements (FeNO, spirometry); had a
voice recorder fitted (for cough counts) and a skin prick test (SPT).
Then the children were randomized to one of two sequences: (1)
exercise challenge performed on day 1 with dry powder mannitol
(Aridol™) challenge on day 2, or (2) mannitol challenge on day 1
with exercise challenge on day 2. Randomization was undertaken
by an independent person off-site using a computer generation
sequence list in permuted blocks 2–4. Allocation was fully con-
cealed using opaque covers. Our primary outcome measures were
cough frequency pre- and post-exercise challenge, and FeNO lev-
els in children with cough and controls. In this manuscript, we
are reporting data relating to the exercise test component of the
study.
FeNO, SPIROMETRY, AND SKIN PRICK TEST
Fractional exhaled nitric oxide was measured with a chemilumi-
nescence analyzer (Sievers NOA 280i, CO, USA) with children
exhaling at 0.05 L/s for>4 s in order to obtain a stable nitric oxide
value for>2 s, in accordance with ATS/ERS guidelines (10). Exha-
lations were repeated until three measurements were within 5%
of the mean. Spirometry was performed after FeNO measure-
ments using ATS/ERS criteria and the % predicted calculated based
on height, age and sex matched reference values [Eigen (11) and
Hibbert (12)].
Allergens used for SPT were alternaria mold, cat hair, cockroach
mix, dust mite DPT, couch grass, and grass mix #7 (Hollister-Stier,
WA, USA). Negative (diluents) and positive (histamine) controls
were also used. Atopy was defined as wheal ≥3 mm larger than
that of the histamine control after 15 min.
OBJECTIVE COUGH MONITORING
A digital voice recorder (Sony PCP330F, Japan) recorded contin-
uously for 24 h after being fitted post-randomization. The file
(MP3) was downloaded and replayed. The time and number of
coughs were manually counted by a person blinded to the child’s
other data and recorded in a spreadsheet. Whilst the MP3 file was
being listened to, the times of all challenges were recorded,enabling
the coughs to be analyzed dependent on challenges. Additionally,
the listener recorded the time the child seemed to be sleeping and
awake. Wakefulness was defined as when the child could be heard
talking or being active.
EXERCISE CHALLENGE
The exercise challenge was undertaken in accordance to on
ATS/ERS guidelines (13) using a treadmill (Trackmaster™
TMX425CP, USA). Room temperature and relative humidity
were regulated by air conditioning to keep the water content
≤10 mg/mL (14). Children were required to withhold medications
that could influence bronchial challenges (Table A1 in Appendix).
FIGURE 1 | Flowchart of methods.
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Pulse oximetry was monitored during exercise testing. Treadmill
slope and speed were adjusted to achieve target heart rates of at
least 85% of maximum predicted (220 – age in years) within
the first 2–4 min of exercise (15). Children continued exercise
to achieve at least 4 min at the target heart rate, or, alternatively,
until symptoms of dyspnea or fatigue required the patient to stop.
Spirometry was performed post challenge at 1, 5, 10, and 15 min
after the end of exercise. EIB was defined as a decrease in FEV1
≥13% from baseline measurement (16).
STATISTICAL ANALYSES
Descriptive statistics were used to summarize the demographic
characteristics of the patients. Data that had a normal distribu-
tion were described using means and standard deviations (SD);
medians and inter-quartile ranges (IQR) were used otherwise.
Chi squared tests were employed for categorical data. Correla-
tions were made using Spearman’s correlation (r s). Kruskal–Wallis
analyses were used for group comparisons. Two-tailed p values of
<0.05 were considered significant. All analyses were performed
using a statistical package, SPSS Version 13.
RESULTS
We recruited 50 children between March 2006 and August 2008,
of whom 49 were randomized. One child was not randomized
as that parent did not consent to the mannitol challenge. One
child (aged 6 years) commenced but could not complete the exer-
cise challenge (cried) nor the mannitol challenge. Thus, data for
cough and exercise were limited to 48 children (Table 1). Although
the clinicians’ question was whether the current cough related to
EIB, the underlying etiology of children with cough at the point
of enrollment were: unknown, i.e., referred for determination of
cough (n= 11, 33.3%), asthma (n= 10, 30.3%), cystic fibrosis (but
referred for exercise test due to suspected EIB) (n= 8, 24.3%), sus-
pected tracheomalacia (n= 1, 3%), congenital lobar emphysema
(n= 1, 3%), follicular bronchiolitis (n= 1, 3%), and viral upper
respiratory tract infection (n= 1, 3%). In the 11 children who
did not have any diagnosis at the point of referral, the final diag-
nosis was asthma= 4, non-cystic fibrosis bronchiectasis= 2, and
protracted bacterial bronchitis= 5.
COUGH COUNTS
The median baseline cough count whilst the child was awake (total
number of coughs not during airway challenges/hours awake)
was significantly higher in the coughers compared to controls
(Table 2). There was no significant difference between cougher
and control groups in the number of coughs 30 min pre-exercise.
However post-exercise, the median number of coughs was signif-
icantly higher in the coughers compared to controls (Figure 2).
As the control children had little cough, the difference in cough
frequency between 30 min pre and 30 min post-exercise was not
significant between groups. None of the controls coughed during
the exercise challenge but 13 of 33 children in the coughing group
coughed [median number of coughs in these 13 children was 5
(IQR 2, 27)].
There was no significant difference in change of cough fre-
quency in the 30 min post-exercise between children with and
without EIB [EIB positive (n= 7): median 15.0 (IQR 0, 44.3); EIB
Table 1 | Baseline data.
Coughers
(n=33)
Controls
(n=15)
DEMOGRAPHICS
Boys:girls; n (%) 21 (63.6):12 (36.4) 5 (33.3):10 (66.7)
Age in yearsa 9.5 (7.8, 12.8) 11.75 (10.1, 14.8)
Atopy present; n (%) 16 (47.1) 3 (17.7)
HISTORY
Prescribed asthma treatment; n (%) 20 (58.8)
Duration of cough history (months)a 84 (48, 143) N/A
INVESTIGATIONS
FEV1 % predicteda 89.5 (82.6, 98.9) 95.0 (83.0, 99.0)
FeNO parts per billiona 12.1 (7.3, 34.0) 19.3 (11.5, 30.9)
aMedian (IQR).
negative (n= 31): median 5.0 (IQR 0, 16.0); p= 0.63]. There was
also no difference in cough frequency between children grouped
by presence of atopy [atopy present (n= 19): median 3.5 (IQR 1.7,
7.5); atopy absent (n= 29): 3.8 (IQR 0.7, 11.9); p= 0.91]. There
was no difference in cough frequency post exercise when grouping
by diagnosis in the children with cough (p= 0.78).
FeNO LEVELS
At baseline measurement of FeNO, there was no significant differ-
ence (p= 0.089) between the coughers and controls (Table 1). In
both groups, FeNO levels fell post-exercise at 5 min compared to
baseline and there was no significant difference between groups
[Coughers: median−2.6 ppb (IQR−0.55,−4.35]; controls:−5.9
(IQR−1.0,−7.4), p= 0.158]. The fall in FeNO was larger in chil-
dren with EIB [median −7.5 (IQR −3.0, −15.3)] compared to
those without EIB (median−2.5, IQR−0.7,−5.98) but the differ-
ence did not reach significance (p= 0.06). There was no significant
difference in decrease of FeNO between those with atopy (median
−3.65, IQR−7.1,−0.88) and those without atopy (median−2.6,
IQR−6.45,−0.75), p= 0.822.
DISCUSSION
To our knowledge, this study is the first to evaluate the effect of
exercise on objective cough counts in children with and without
a pre-existing cough. Our study found that with exercise, children
with a current cough have an increase in cough frequency even
in the absence of EIB or atopy. Also, the trend demonstrated a
larger decrease in FeNO levels post-exercise in children with EIB,
compared to those without EIB. Finally, atopy did not influence
the change in FeNO levels post-exercise.
Cough with exercise or post-exercise is not rare and is some-
times used as a marker of asthma in children and adults (2,
3). Delineating whether exercise-associated cough really reflects
asthma would be useful in clinical practice, particularly in chil-
dren. Yet, to date there are no publications that have objectively
quantified exercise-associated cough and examined its association
with EIB in children. Objective quantification of cough is impor-
tant in research studies on cough (5). In our cohort, albeit small,
we found that post exercise cough objectively quantified was sig-
nificantly higher in coughers (with and without EIB or atopy)
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Table 2 | FeNO and objective cough counts between the groups.
Coughers (N =33) Controls (N =15) pValue
EIB (≥13% fall in FEV1); n (%) 7 (20) 0 0.06
FeNO at 5 min post exercise (ppb)a 9.2 (5.3, 28.1) 11.4 (7.2, 23.5) 0.37
Number of coughs in 30 min pre-exercisea 2.0 (0, 5.0) 0 (0, 2.75) 0.11
Number of cough in 30 min post-exercisea 7.0 (0.5, 24.5) 2.0 (0, 5.0) 0.03
Difference in cough counts (post 30 min minus pre 30 min)a 5.5 (0, 18.8) 0 (−2.2, 0) 0.09
Coughs/hr while awake (time excludes AHR challenges)a 6.7 (2, 12.2) 1.2 (0.4, 2.9) 0.001
aMedian (IQR).
The bold font highlights statistical significance.
FIGURE 2 | Box plot (median and IQR) depicting the number of coughs
30min post exercise in the coughers and controls. The median number
of coughs was significantly higher in the coughers compared to controls.
compared to controls. This suggests cough frequency with exer-
cise is a generic response and not limited to children with EIB.
Whether or not those with EIB have an even greater increase in
cough frequency post exercise compared to those without EIB
remains unanswered as our sample size is too small.
In adults, several studies have examined cough in relation to
several tests of airway hyper-responsiveness and have suggested
that cough can be used as a marker of asthma. However,others have
shown that medications used to abolish the broncho-constriction
effect did not influence the cough response (17–19). In pediatric
clinical practice, arguably delineating cough in relation to exercise
is more applicable than that to other airway challenges. Suguikawa
et al. evaluated cough in 20 adults with asthma who underwent
methacholine, bradykinin, and exercise challenge tests (3). There
was discordance among the tests for the frequency of cough.
Bradykinin induced the most cough and exercise-induced the least
(20). To our knowledge, the study by Suguikawa et al. (3) is the sole
paper that have objectively monitored cough in relation to exercise.
As early as 1999, Rietveld and colleagues (21) questioned the
use of cough alone as a marker of airway obstruction. In 30
children with asthma, they described the discordance between
cough with other markers of asthma severity during a histamine
challenge. Current Australian cough guidelines in children (22)
recommend that chronic cough without any other features is sel-
dom due to asthma, and inhaled corticosteroids are not indicated
unless there are positive features to suggest asthma. However, the
guidelines do not discuss cough with exertion and neither does
the British Thoracic Society guidelines (23). Nevertheless, other,
asthma-guidelines state that children with asthma may have an
increase in cough during exercise (24), although this has never
been evaluated using objective cough counts.
There are only a few studies that have related FeNO levels with
cough or FeNO values post exercise. Our data showed a small but
significant decrease in FeNO change post-exercise. Further, the
fall in FeNO was small and within the coefficient of variant of
the FeNO instrument used. Nevertheless, our data supports the
findings of Terada et al. (8) but are in contrast to Scollo et al.
(9) However, our study adds further novel data as neither studies
examined FeNO in children with cough but without asthma. The
fall in FeNO post exercise was larger in children with EIB and this
difference between groups did not reach statistical significance. A
larger study is required to examine this question. Several studies
(25–27) conducted with healthy adults have found that during
exercise FeNO decreases, whereas NO output increases.
As atopy is sometimes considered a surrogate of asthma in
the presence of respiratory symptoms (20), we also examined the
influence of atopy on our outcomes of interest. Our data showed
that the presence of atopy did not influence the increase in cough
frequency with exercise or 24-h cough frequency. This is consistent
with our previous data showing that in children, cough sensitivity
is not influenced by atopy (28).
Our study has many limitations that include a small sample
size. A type-II error is thus invariably present for EIB and cough,
as noted above. We had intended to recruit 100 children in total
but the study was stopped early for feasibility reasons. Hence, in
effect, this study represents pilot data. Accurate sample size calcu-
lation was not possible given the absence of data prior to this study.
Secondly, we recruited children who were old enough to perform
spirometry and exercise challenges and this limits applicability to
younger children who are the largest age group of children referred
for chronic cough (29). The studies were conducted more than
4 years ago but only recently analyzed. The delay related to per-
sonal circumstances of the primary author. We do not believe this
represents a bias.
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Another limitation is the heterogenous nature of the children
with cough. However, our cohort represented real-life clinical set-
tings where clinicians queried whether the current cough with
exercise is a reflective of EIB and hence whether or not the child
should receive more asthma medications. In clinical practice,
even children with an underlying disorder such as cystic fibro-
sis may have increased cough with exercise that may or may not
be reflective of their underlying respiratory diagnosis.
In spite of our study’s limitations, we have provided novel
data relating cough frequency objectively measured with exer-
cise in children with and without cough. Further we examined
this relationship with respect to FeNO levels, EIB, and atopy. In
conclusion, children with current cough have increased cough fre-
quency post exercise even in the absence of EIB. In the absence of
other symptoms, exercise-induced cough is likely a poor marker
of asthma but a larger cohort study is required to verify whether
children with EIB cough more than those without EIB in response
to exercise.
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APPENDIX
Table A1 | Drugs withheld prior to commencement of protocol.
Long acting beta agonists For 12 h
Beta-2-agonists For 6–8 h
Singulair (leukotriene-receptor antagonist) For 4 days
Sodium cromoglycate and nedocromil For 8 h
Antihistamines For 72 h
Inhaled corticosteroids For 12 h
Caffeine (cola, chocolate, coffee, tea) For 8 h
Strenuous exercise For 6 h
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